Ensoma, an in vivo hematopoietic stem cell (HSC) engineering company with a mission to advance the future of medicine through one-time therapies, today announced new preclinical data demonstrating ...

Chronic subdural hematoma (cSDH) is frequently encountered in neurosurgical practice. Apart from traditional treatment approaches, such as surgical intervention or medical management, middle meningeal ...